Meeder Asset Management’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-5,632
| Closed | -$43K | – | 595 |
|
|
2022
Q4 | $43K | Buy |
5,632
+4,523
| +408% | +$34.6K | ﹤0.01% | 537 |
|
|
2022
Q3 | $8K | Buy |
1,109
+522
| +89% | +$3.77K | ﹤0.01% | 1386 |
|
|
2022
Q2 | $5K | Buy |
587
+293
| +100% | +$2.5K | ﹤0.01% | 1623 |
|
|
2022
Q1 | $4K | Buy |
+294
| New | +$4K | ﹤0.01% | 1836 |
|
|
2021
Q4 | – | Sell |
-33
| Closed | -$1K | – | 1112 |
|
|
2021
Q3 | $1K | Sell |
33
-7
| -18% | -$212 | ﹤0.01% | 2269 |
|
|
2021
Q2 | $2K | Hold |
40
| – | – | ﹤0.01% | 2176 |
|
|
2021
Q1 | $2K | Hold |
40
| – | – | ﹤0.01% | 2047 |
|
|
2020
Q4 | $2K | Hold |
40
| – | – | ﹤0.01% | 1440 |
|
|
2020
Q3 | $2K | Sell |
40
-8
| -17% | -$400 | ﹤0.01% | 1792 |
|
|
2020
Q2 | $2K | Sell |
48
-18
| -27% | -$750 | ﹤0.01% | 1736 |
|
|
2020
Q1 | $2K | Buy |
66
+60
| +1,000% | +$1.82K | ﹤0.01% | 2050 |
|
|
2019
Q4 | $0 | Buy |
+6
| New | – | ﹤0.01% | 2221 |
|